title: Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease.
authors.affiliation: Department of Gastroenterology, Kitakyushu Municipal Medical Center, Kitakyushu, Fukuoka, Japan.
authors.forename: Soichi
authors.initials: S
authors.lastname: Itaba
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Iwasa
authors.forename: Yojiro
authors.initials: Y
authors.lastname: Sadamoto
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Nasu
authors.forename: Tadashi
authors.initials: T
authors.lastname: Misawa
authors.forename: Koji
authors.initials: K
authors.lastname: Inoue
authors.forename: Hidehiko
authors.initials: H
authors.lastname: Shimokawa
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Nakamura
authors.forename: Ryoichi
authors.initials: R
authors.lastname: Takayanagi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000069285:Infliximab; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000209:etiology*; D011239:Prednisolone / Q000009:adverse effects*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011239:Prednisolone; D000069285:Infliximab; D001379:Azathioprine